Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $18,212 | 1,237 | 99.7% |
| Education | $58.59 | 7 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,724 | 110 | $0 (2024) |
| ABBVIE INC. | $1,641 | 109 | $0 (2024) |
| Merck Sharp & Dohme LLC | $1,259 | 80 | $0 (2024) |
| Lilly USA, LLC | $1,193 | 123 | $0 (2024) |
| Amgen Inc. | $1,191 | 70 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,118 | 55 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,074 | 88 | $0 (2024) |
| PFIZER INC. | $1,035 | 69 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $975.39 | 109 | $0 (2024) |
| Allergan, Inc. | $771.80 | 64 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,339 | 144 | ABBVIE INC. ($341.19) |
| 2023 | $2,383 | 147 | AbbVie Inc. ($319.85) |
| 2022 | $2,837 | 193 | ABBVIE INC. ($541.54) |
| 2021 | $2,499 | 158 | AbbVie Inc. ($316.46) |
| 2020 | $1,921 | 130 | Novo Nordisk Inc ($240.41) |
| 2019 | $1,948 | 133 | Allergan Inc. ($248.46) |
| 2018 | $2,133 | 151 | GlaxoSmithKline, LLC. ($281.61) |
| 2017 | $2,211 | 188 | Novo Nordisk Inc ($336.77) |
All Payment Transactions
1,244 individual payment records from CMS Open Payments — Page 1 of 50
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $16.44 | General |
| Category: RESPIRATORY | ||||||
| 12/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.97 | General |
| Category: NEUROSCIENCE | ||||||
| 12/12/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: Respiratory | ||||||
| 11/19/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $16.65 | General |
| Category: PSYCHIATRY | ||||||
| 11/18/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.35 | General |
| Category: Inflammation | ||||||
| 11/13/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $10.42 | General |
| Category: Diabetes | ||||||
| 11/12/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $6.03 | General |
| Category: Diabetes | ||||||
| 11/07/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $16.02 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/06/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $104.32 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.99 | General |
| Category: NEUROSCIENCE | ||||||
| 11/05/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $9.41 | General |
| Category: Obesity | ||||||
| 10/24/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $16.39 | General |
| Category: Bone Health | ||||||
| 10/24/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $7.33 | General |
| Category: Inflammation | ||||||
| 10/21/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $15.41 | General |
| Category: RESPIRATORY | ||||||
| 10/21/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $1.13 | General |
| Category: RESPIRATORY | ||||||
| 10/17/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.07 | General |
| Category: Diabetes | ||||||
| 10/15/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $20.67 | General |
| Category: PAIN | ||||||
| 10/08/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: NEUROSCIENCE | ||||||
| 10/07/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $22.20 | General |
| Category: Cardiovascular | ||||||
| 10/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $29.84 | General |
| Category: NEUROSCIENCE | ||||||
| 09/30/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $20.20 | General |
| Category: Biological | ||||||
| 09/30/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $14.75 | General |
| Category: SCHIZOPHRENIA | ||||||
| 09/23/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: Inflammation | ||||||
| 09/19/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $26.38 | General |
| Category: Diabetes | ||||||
| 09/11/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $109.06 | General |
| Category: Cardio-renal | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 25 | 1,345 | 2,491 | $354,484 | $141,632 |
| 2022 | 29 | 1,326 | 2,557 | $336,105 | $126,022 |
| 2021 | 30 | 1,495 | 2,694 | $380,103 | $144,179 |
| 2020 | 28 | 1,536 | 2,913 | $358,094 | $122,813 |
All Medicare Procedures & Services
112 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 214 | 366 | $82,308 | $29,830 | 36.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 220 | 452 | $69,878 | $26,663 | 38.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 87 | 87 | $20,097 | $11,072 | 55.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 35 | 106 | $22,578 | $10,104 | 44.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 57 | 151 | $22,348 | $9,149 | 40.9% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 46 | 155 | $21,700 | $8,729 | 40.2% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 27 | 147 | $12,348 | $7,052 | 57.1% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 39 | 42 | $15,456 | $6,435 | 41.6% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 60 | 76 | $11,324 | $4,695 | 41.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 32 | 35 | $14,490 | $4,694 | 32.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 60 | 60 | $7,200 | $4,316 | 59.9% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 26 | 44 | $8,096 | $3,601 | 44.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 35 | 36 | $10,188 | $3,483 | 34.2% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 29 | 46 | $5,888 | $2,340 | 39.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 64 | 64 | $3,776 | $1,935 | 51.3% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 34 | 47 | $5,029 | $1,830 | 36.4% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 83 | 83 | $2,988 | $1,487 | 49.8% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 17 | 17 | $2,941 | $1,159 | 39.4% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 20 | 33 | $2,673 | $971.10 | 36.3% |
| 20552 | Injection of trigger points, 1-2 muscles | Office | 2023 | 19 | 22 | $2,508 | $821.12 | 32.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 25 | 43 | $2,580 | $424.35 | 16.4% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 28 | 28 | $1,120 | $266.56 | 23.8% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2023 | 20 | 20 | $600.00 | $247.00 | 41.2% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 48 | 306 | $6,120 | $243.16 | 4.0% |
| 81002 | Urinalysis, manual test | Office | 2023 | 20 | 25 | $250.00 | $85.25 | 34.1% |
About John Spence, M. D
John Spence, M. D is a Family Medicine healthcare provider based in Marianna, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1497794796.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, John Spence, M. D has received a total of $18,271 in payments from pharmaceutical and medical device companies, with $2,339 received in 2024. These payments were reported across 1,244 transactions from 61 companies. The most common payment nature is "Food and Beverage" ($18,212).
As a Medicare-enrolled provider, Spence has provided services to 5,702 Medicare beneficiaries, totaling 10,655 services with total Medicare billing of $534,646. Data is available for 4 years (2020–2023), covering 112 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Marianna, FL
- Active Since 06/05/2006
- Last Updated 11/22/2022
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1497794796
Products in Payments
- VRAYLAR (Drug) $1,222
- Ozempic (Drug) $966.02
- XARELTO (Drug) $946.05
- FARXIGA (Drug) $874.97
- Kerendia (Drug) $600.82
- TRELEGY ELLIPTA (Drug) $585.11
- Otezla (Drug) $496.92
- NURTEC ODT (Drug) $467.54
- BELSOMRA (Drug) $437.05
- JANUVIA (Drug) $436.14
- MOUNJARO (Drug) $394.27
- ELIQUIS (Drug) $378.55
- Victoza (Drug) $371.60
- TRULICITY (Drug) $366.81
- ENTRESTO (Drug) $361.37
- Aimovig (Biological) $329.04
- CHANTIX (Drug) $296.68
- JARDIANCE (Drug) $289.05
- Livalo (Drug) $251.53
- ANORO (Drug) $250.23
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Marianna
Mark Akerson, Md, MD
Family Medicine — Payments: $17,983
Harrison Fuqua, Md, MD
Family Medicine — Payments: $2,277
Richard Brunner, M.d, M.D
Family Medicine — Payments: $1,915
William Harris, Md, MD
Family Medicine — Payments: $173.09
Dr. Susan Balke, Do, DO
Family Medicine — Payments: $110.55
Thomas Bailey, Md, MD
Family Medicine — Payments: $92.28